Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Outsourcing-Pharma

17:32 EDT 18th June 2018 | BioPortfolio

Here are the most relevant search results for "Outsourcing-Pharma" found in our extensive news archives from over 250 global news sources.

More Information about Outsourcing-Pharma on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Outsourcing-Pharma for you to read. Along with our medical data and news we also list Outsourcing-Pharma Clinical Trials, which are updated daily. BioPortfolio also has a large database of Outsourcing-Pharma Companies for you to search.

Showing News Articles 1–25 of 447 from Outsourcing-Pharma

Monday 18th June 2018

NIH halts trial funding following ‘significant process irregularities’

The NIH has halted funding for a clinical trial â funded in part by several beverage and brewing companies â after a review found employees violated NIH policies in soliciting gift funding.

Evotec takes on Sanofi’s infectious disease unit as it aims to develop new anti-infectives

Evotec is integrating Sanofiâs infectious disease unit into its organization and will collaborate to launch new "open innovation" initiatives aimed at accelerating infectious disease research.

Thursday 14th June 2018

Medidata looks to deliver ‘digital transformation’ with Shyft Analytics deal

Medidata is acquiring Shyft Analytics for $195m, creating a new platform that will combine clinical development with commercial and real-world data analytics in a first for the industry, says a company executive.

Asia-Pacific CRO Novotech signs MOU with Chinese hospital

Novotech has signed a Memorandum of Understanding (MOU) with the China Medical University Hospital (CMUH) in Taiwan.

European CRO Optimapharm enters US market

The Croatia-headquartered contract research organization (CRO) has opened its first office in the US and plans to further expand its footprint organically and through potential acquisitions.

Wednesday 13th June 2018

MediPharma develops ‘smart’ blister to improve patient compliance

A blister pack that generates data on the medication type and extraction time has been developed by MediPharm to improve patient compliance.

AI-informed virtual assistant to help solve ‘stubborn problems,’ says Saama

Saama has launched a set of artificial intelligence (AI) capabilities designed to understand "typical life science domain questions" to better support clinical trial planning, feasibility, and conduct.

Marken upgrades, expands Chicago logistics hub

Marken this week has announced the relocation of its Chicago logistics hub into a new, larger facility equipped with cold chain technology for clinical trial materials shipments.

Tuesday 12th June 2018

Covance bolsters pharmacovigilance services with Sciformix acquisition

Covance has acquired Sciformix in a deal that augments the CROâs pharmacovigilance capabilities for post-approval safety solutions and expands its global footprint.

After raising $85m, SutroVax contracts Lonza to support vaccine development

Lonza is supporting SutroVaxâs development of its pneumococcal conjugate vaccine candidate through an end-to-end supply relationship.

Syneos to lay off 98 amid changing business needs

Syneos Health will be reducing operations at its Indianapolis, IN-based facility following âshifting customer needs,â says spokesperson.

Monday 11th June 2018

Wasdell invests £500k in new UK-based lab, offerings to be replicated in Ireland

Wasdell Group is investing Â500k ($669k) in a new laboratory as the first phase of an expansion strategy, which includes a similar investment in Ireland "to cater for all situations after Brexit," says managing director.

State of the Industry: Taking the pulse of the contract services market

Following on from the success of last year's survey, Outsourcing-Pharma is running another 'state of the industry' survey to gauge views about the current state of the pharmaceutical contract services industry.

Thursday 7th June 2018

Preclinical CRO Admescope acquires MetaSafe to up drug metabolism services

The preclinical contract research organization (CRO) Admescope has acquired MetaSafe in a deal which will bolster its drug metabolism services for clinical phase projects.

PPD: Meeting biopharma demand is a ‘substantial undertaking’ for CRO industry

PPD Laboratories SVP says its been a substantial undertaking â for every company in the CRO industry â to meet the demand for biopharmaceuticals as the industry's pipeline continues to expand.

Wednesday 6th June 2018

Japan v. China: Becoming two of the largest pharma markets in the world

Chinaâs pharmaceutical market has outpaced Japanâs to become the second largest market globally â as both aim to become the location of choice for companies developing and launching new innovations, say Parexel consultants.

AMRI awarded seven-year NIH contract

AMRI will support the development and manufacture of active pharmaceutical ingredients (API) and drug product for Phase I clinical studies under a seven-year contract with the NIH.

Celltrion gets into outsourcing with Bio CDMO launch

Celltrion has launched Bio CDMO, its new contract development and manufacturing business and part of the company's "open innovation strategy" to expand its drug pipeline portfolio.

Tuesday 5th June 2018

New PE owners say Alcami is ‘more than capable’ of doubling, tripling in size

Alcami Corporation is set to be acquired by MDP â a private equity firm which believes the CDMO could double or triple in size as a strong brand in a highly fragmented market.

Driven by ‘significant’ organic growth, Almac revenue tops £500m for first time

Almac Group has reported a 19% growth in revenue to Â531m ($709.86m) â a first for the company as it continues to invest globally and drive a strategy of strategically entering new markets, says finance director.

Monday 4th June 2018

Demand for pathology services sparks PPD, NeoGenomics alliance

PPD is teaming up with NeoGenomics Laboratories in response to increasingly complex clinical trials and demand for pathology services, says exec.

Demand for pathology services sparks PPD, NeoGeomics alliance

PPD is teaming up with NeoGenomics Laboratories in response to increasingly complex clinical trials and demand for pathology services, says exec.

Syngene teams with immuno-oncology firm to provide ‘greater value-added services’

Syngene International has inked a non-exclusive partnering agreement with the emerging immuno-oncology company Zumutor Biologics after collaborating for more than a year.

Thursday 31st May 2018

Ergomed establishes new revenue stream, adds specialist pharmacoepidemiology services

Ergomed has added specialist pharmacoepidemiology services at its PrimeVigilance subsidiary to support increasing demand from regulators globally, says CEO.

Altasciences: Altreos alliance to support 'rapidly evolving area of abuse potential assessments'

Altasciences has entered into a strategic alliance with Altreos Research Partners to help clients navigate the âcomplexities of human abuse potential studies,â says CEO.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks